Realizing The Promise: How Personalized Gene Editing Can Treat Ultra-Rare Diseases

With a shared purpose, we can realize the true promise of CRISPR and improve healthcare, providing hope to more patients with ...

Emails show Epstein funded genetic testing in apparent bid to explore life extension

Newly released records reveal the financier paid for genome sequencing and discussed gene editing research tied to longevity.

Epstein paid for novel genetic testing in apparent effort to explore extending life, new emails show

Convicted sex offender Jeffrey Epstein paid for genetic testing in an apparent bid to harness his own genetic material for ...

Brewing possibilities: Using caffeine to edit gene expression

What if a cup of coffee could help treat cancer? Researchers at the Texas A&M Health Institute of Biosciences and Technology ...
Technology Networks

Gene Editing Could Soon Be Applied Like a Skin Cream

A new skin-applied gene therapy uses lipid nanoparticles to deliver gene editing into skin stem cells, correcting ...

Eli Lilly signs up to $1.12 billion deal with private gene-editing firm Seamless

By Mariam Sunny and Bhanvi Satija Jan 28 (Reuters) - U.S. drugmaker Eli Lilly signed an agreement worth up to $1.12 billion ...

Eli Lilly (LLY) Taps Gene-Editing Technology to Target Hearing Loss, Reuters Reports

Eli Lilly and Company (NYSE:LLY) is included among the 12 Best Stocks to Buy for the Long Term. According to a report by ...
Technology Networks

Breakthrough Topical Gene Editing Technology Offers Hope for Skin Conditions

Researchers developed a topical gene therapy that corrects disease-causing mutations in human skin models using lipid ...

Scientists develop first gene-editing treatment for skin conditions

Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the ...
Drug Target Review

New CRISPR-based gene-editing treatment targets root cause of kidney disease

Explore groundbreaking gene-editing therapy for kidney disease, offering hope to those with polycystic kidney disease.

Using AI to keep CRISPR technology in-check

Last year, a ten-month-old baby in the US was the first person in the world to have their rare genetic disease effectively ...

REPROCELL Launches StemEdit - Clinical Gene Editing Services and New iPSC Lines Using AI-Designed editing tools

REPROCELL today announced the commercial launch of StemEdit, its clinical gene editing services and new gene-edited iPSC product lines leveraging OpenCRISPR-1™, an AI-designed genome editing system ...